Moderately severe haemophilia B (Q89199): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Changed label, description and/or aliases in pt-br, en
‎Changed an Item
 
(5 intermediate revisions by the same user not shown)
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/1741015882 / rank
 
Normal rank
Property / CURIE
 
CID11:ID_1741015882
Property / CURIE: CID11:ID_1741015882 / rank
 
Normal rank
Property / Canary Token
 
dki-india-ID_1741015882
Property / Canary Token: dki-india-ID_1741015882 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank

Latest revision as of 15:46, 15 August 2026

Moderately severe haemophilia B is a form of haemophilia B (see this term) characterised by factor IX deficiency leading to abnormal bleeding as a result of minor injuries, or following surgery or tooth extraction. Moderately severe haemophilia B accounts for around 30% of all cases of haemophilia B. The biological activity of factor IX is between 1% and 5%. Spontaneous haemorrhages are rare. Transmission is X-linked recessive and the disorder is caused by mutations in the F9 gene (Xq28) encoding coagulation factor IX.
Language Label Description Also known as
default for all languages
ID_1741015882
    English
    Moderately severe haemophilia B
    Moderately severe haemophilia B is a form of haemophilia B (see this term) characterised by factor IX deficiency leading to abnormal bleeding as a result of minor injuries, or following surgery or tooth extraction. Moderately severe haemophilia B accounts for around 30% of all cases of haemophilia B. The biological activity of factor IX is between 1% and 5%. Spontaneous haemorrhages are rare. Transmission is X-linked recessive and the disorder is caused by mutations in the F9 gene (Xq28) encoding coagulation factor IX.

      Statements

      CID11:ID_1741015882
      0 references
      dki-india-ID_1741015882
      0 references
      Concluído
      0 references
      13 August 2026
      0 references